Inventor · disambiguated record
William R. Sellers
Also filed as: SELLERS WILLIAM · SELLERS WILLIAM R · SELLERS WILLIAM RAJ
17 granted patents·9 pending applications·755 citations·filing 1992–2024
95Inventor score
Files withNOVARTIS AG7DANA FARBER CANCER INST INC4BROAD INST INC3GEN HOSPITAL CORP3MASSACHUSETTS GEN HOSPITAL3
Top patents by PatentIndex Score
26 records- 0198US7964349B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2007·Granted Jun 21, 2011·92 cites·31 claims
- 0298US7294468B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2005·Granted Nov 13, 2007·187 cites·8 claims
- 0396US8465916B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jun 18, 2013·85 cites·21 claims
- 0496US8105769B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jan 31, 2012·97 cites·4 claims
- 0595US10357514B2Treatment of cancer using anti-CD19 Chimeric Antigen ReceptorUNIV PENNSYLVANIA·Filed 2015·Granted Jul 23, 2019·18 cites·45 claims
- 0695US7981609B2Methods for identifying and using SNP panelsBRIGHAM & WOMENS HOSPITAL·Filed 2007·Granted Jul 19, 2011·61 cites·12 claims
- 0794US10287354B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2014·Granted May 14, 2019·29 cites·63 claims
- 0894US6949342B2Prostate cancer diagnosis and outcome prediction by expression analysisDANA FARBER CANCER INST INC·Filed 2002·Granted Sep 27, 2005·152 cites·7 claims
- 0991US7501248B2Prostate cancer diagnosis and outcome prediction by expression analysisWHITEHEAD BIOMEDICAL INST·Filed 2005·Granted Mar 10, 2009·15 cites·8 claims
- 1089US9035036B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2013·Granted May 19, 2015·8 cites·26 claims
- 1183US11578130B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Feb 14, 2023·1 cites·30 claims
- 1283US11530413B2Compositions and methods to treat cancerNOVARTIS AG·Filed 2018·Granted Dec 20, 2022·3 cites·6 claims
- 1376US2025101435A1Compositions and methods to treat cancerNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1475US12006555B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jun 11, 2024·0 cites·16 claims
- 1573US10669589B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jun 2, 2020·0 cites·13 claims
- 1672US2023026049A1Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1770US2024052354A1Compositions and methods to treat cancerNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1867US2025084453A1Systems, compositions and methods for identifying e3 ligase substrates by ubiquitin biotinylationBROAD INST INC·Filed 2024·Application pending·0 cites
- 1962US2019388471A1Treatment of cancer using anti-cd19 chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2059US10000815B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Jun 19, 2018·0 cites·32 claims
- 2159US2006008838A1Prostate cancer diagnosis and outcome prediction by expression analysisDANA FARBER CANCER INST INC·Filed 2005·Application pending·0 cites
- 2247US2023295308A1Antagonistic biparatopic antibodies that specifically bind fibroblast growth factor receptor 2 and methods of using sameBROAD INST INC·Filed 2021·Application pending·0 cites
- 2346US5759803ARecombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNADANA FARBER CANCER INST INC·Filed 1992·Granted Jun 2, 1998·7 cites·42 claims
- 2443US2010305150A1Tuberous sclerosis treatmentBERG WILLIAM·Filed 2007·Application pending·0 cites
- 2541US2021401953A1Asparaginase therapeutic methodsBROAD INST INC·Filed 2019·Application pending·0 cites
- 2627US5981723ARetinoblastoma-associated protein 1 CDNADANA FARBER CANCER INST INC·Filed 1995·Granted Nov 9, 1999·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when William R. Sellers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →